Finance Watch: Lightstone Ventures Closes $375m Fund To Back Early Stage Biotechs

General Partner Jason Lettmann Expects IPO Exits To Continue

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.